News
Medi Assist’s Raksha Prime surpasses 2 lakh cashless discharges: Our Bureau, Bengaluru Tuesday, July 15, 2025, 16:15 Hrs [IST] Medi Assist, India’s leading health benefits adm ...
Earendil Labs initiates phase 1 study of novel anti-TL1A antibody to evaluate safety and tolerability of HXN-1001: Middletown Tuesday, July 15, 2025, 16:00 Hrs [IST] Earendil Labs ...
Appy Healthcare’s cashless OPD to tackle India’s 45% of out-of-pocket healthcare expenses: Our Bureau, Bengaluru Tuesday, July 15, 2025, 15:40 Hrs [IST] zAppy Healthcare has ...
NIO Super Specialty Hospital expands its services with new clinics and technology integration: Our Bureau, Bengaluru Tuesday, July 15, 2025, 15:30 Hrs [IST] National Institute of ...
Meril Lifesciences concludes TechVentory programme, driving the future of healthcare supply chains with AI: Our Bureau, ...
Intelligent Bio Solutions to present Pharmacokinetic study data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo: New York Tuesday, July 15, 2025, 15: ...
Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, announced upcoming presentations at ...
Arcus Biosciences’ quemliclustat receives US FDA orphan drug designation to treat pancreatic cancer: Hayward, California Tuesday, July 15, 2025, 13:00 Hrs [IST] Arcus Bioscience ...
ViiV & MPP extend voluntary licensing long-acting injectable HIV treatment, Indian pharma to benefit
ViiV & MPP extend voluntary licensing long-acting injectable HIV treatment, Indian pharma to benefit: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:45 Hrs [IST] ViiV Healthcare ...
Agilus Diagnostics launches new Anti-MCV antibody test that provides early RA diagnosis, improves patient outcomes: Our Bureau, Bengaluru Tuesday, July 15, 2025, 12:15 Hrs [IST] A ...
BriaCell Therapeutics Corporation announces updated phase 2 data of Bria-IMT, shows survival advantage over Trodelvy in metastatic breast cancer: Philadelphia & Vancouver, British ...
Elegen, Nutcracker Therapeutics to pilot cell-free manufacturing process for RNA-based personalized cancer therapeutics: San Francisco Tuesday, July 15, 2025, 11:00 Hrs [IST] Eleg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results